Annual Operating Profit
-$5.75 M
-$3.45 M-150.03%
31 December 2023
Summary:
ImmuCell annual operaing income is currently -$5.75 million, with the most recent change of -$3.45 million (-150.03%) on 31 December 2023. During the last 3 years, it has fallen by -$4.37 million (-316.40%). ICCC annual operating profit is now -370.84% below its all-time high of $2.12 million, reached on 31 December 2015.ICCC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$574.90 K
+$811.70 K+58.54%
30 September 2024
Summary:
ImmuCell quarterly operating income is currently -$574.90 thousand, with the most recent change of +$811.70 thousand (+58.54%) on 30 September 2024. Over the past year, it has increased by +$609.10 thousand (+51.44%). ICCC quarterly operating profit is now -162.61% below its all-time high of $918.20 thousand, reached on 31 March 2017.ICCC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$3.27 M
+$609.10 K+15.72%
30 September 2024
Summary:
ImmuCell TTM operating income is currently -$3.27 million, with the most recent change of +$609.10 thousand (+15.72%) on 30 September 2024. Over the past year, it has increased by +$3.11 million (+48.81%). ICCC TTM operating profit is now -253.84% below its all-time high of $2.12 million, reached on 31 December 2015.ICCC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ICCC Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -150.0% | +51.4% | +48.8% |
| 3 y3 years | -316.4% | -312.1% | -525.0% |
| 5 y5 years | -167.8% | -33.8% | -99.4% |
ICCC Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -2333.1% | at low | -200.8% | +74.5% | -371.5% | +48.8% |
| 5 y | 5 years | -2333.1% | at low | -200.8% | +74.5% | -371.5% | +48.8% |
| alltime | all time | -370.8% | at low | -162.6% | +74.5% | -253.8% | +48.8% |
ImmuCell Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$574.90 K(-58.5%) | -$3.27 M(-15.7%) |
| June 2024 | - | -$1.39 M(+362.0%) | -$3.87 M(+2.2%) |
| Mar 2024 | - | -$300.10 K(-70.1%) | -$3.79 M(-34.0%) |
| Dec 2023 | -$5.75 M(+150.0%) | -$1.00 M(-15.2%) | -$5.75 M(-9.9%) |
| Sept 2023 | - | -$1.18 M(-9.2%) | -$6.38 M(+9.8%) |
| June 2023 | - | -$1.30 M(-42.2%) | -$5.81 M(+13.4%) |
| Mar 2023 | - | -$2.26 M(+38.1%) | -$5.13 M(+122.9%) |
| Dec 2022 | -$2.30 M(-993.1%) | -$1.63 M(+164.9%) | -$2.30 M(+342.3%) |
| Sept 2022 | - | -$616.80 K(-0.4%) | -$519.80 K(-241.2%) |
| June 2022 | - | -$619.00 K(-208.5%) | $368.10 K(-69.4%) |
| Mar 2022 | - | $570.60 K(+292.4%) | $1.20 M(+367.2%) |
| Dec 2021 | $257.40 K(-118.6%) | $145.40 K(-46.4%) | $257.40 K(-149.3%) |
| Sept 2021 | - | $271.10 K(+25.8%) | -$522.40 K(-50.0%) |
| June 2021 | - | $215.50 K(-157.5%) | -$1.05 M(-46.5%) |
| Mar 2021 | - | -$374.60 K(-41.0%) | -$1.95 M(+41.4%) |
| Dec 2020 | -$1.38 M(+44.7%) | -$634.40 K(+152.1%) | -$1.38 M(+39.6%) |
| Sept 2020 | - | -$251.60 K(-63.6%) | -$988.50 K(-15.3%) |
| June 2020 | - | -$691.30 K(-451.1%) | -$1.17 M(+14.1%) |
| Mar 2020 | - | $196.90 K(-181.2%) | -$1.02 M(+7.2%) |
| Dec 2019 | -$953.90 K(-55.6%) | -$242.50 K(-43.6%) | -$953.90 K(-41.7%) |
| Sept 2019 | - | -$429.80 K(-21.4%) | -$1.64 M(-20.4%) |
| June 2019 | - | -$546.90 K(-306.1%) | -$2.06 M(+20.8%) |
| Mar 2019 | - | $265.30 K(-128.7%) | -$1.70 M(-20.7%) |
| Dec 2018 | -$2.15 M(+784.1%) | -$925.90 K(+9.0%) | -$2.15 M(+31.4%) |
| Sept 2018 | - | -$849.10 K(+339.0%) | -$1.63 M(+28.9%) |
| June 2018 | - | -$193.40 K(+8.5%) | -$1.27 M(-5.4%) |
| Mar 2018 | - | -$178.20 K(-56.9%) | -$1.34 M(+451.6%) |
| Dec 2017 | -$242.80 K(-127.3%) | -$413.30 K(-14.3%) | -$242.80 K(-183.8%) |
| Sept 2017 | - | -$482.40 K(+81.8%) | $289.80 K(-64.8%) |
| June 2017 | - | -$265.30 K(-128.9%) | $822.70 K(-25.8%) |
| Mar 2017 | - | $918.20 K(+669.7%) | $1.11 M(+24.6%) |
| Dec 2016 | $890.20 K(-58.1%) | $119.30 K(+136.2%) | $890.30 K(-27.8%) |
| Sept 2016 | - | $50.50 K(+134.9%) | $1.23 M(-31.9%) |
| June 2016 | - | $21.50 K(-96.9%) | $1.81 M(-9.6%) |
| Mar 2016 | - | $699.00 K(+51.5%) | $2.00 M(-5.7%) |
| Dec 2015 | $2.12 M(-1128.2%) | $461.40 K(-26.4%) | $2.12 M(+14.1%) |
| Sept 2015 | - | $626.90 K(+192.9%) | $1.86 M(+46.0%) |
| June 2015 | - | $214.00 K(-73.9%) | $1.27 M(+111.9%) |
| Mar 2015 | - | $820.10 K(+312.3%) | $601.20 K(-391.4%) |
| Dec 2014 | -$206.40 K(+953.1%) | $198.90 K(+386.3%) | -$206.30 K(-66.5%) |
| Sept 2014 | - | $40.90 K(-108.9%) | -$615.20 K(-24.6%) |
| June 2014 | - | -$458.70 K(-3740.5%) | -$816.10 K(+144.6%) |
| Mar 2014 | - | $12.60 K(-106.0%) | -$333.70 K(+1602.6%) |
| Dec 2013 | -$19.60 K(-108.0%) | -$210.00 K(+31.3%) | -$19.60 K(-109.7%) |
| Sept 2013 | - | -$160.00 K(-775.1%) | $202.90 K(-26.7%) |
| June 2013 | - | $23.70 K(-92.7%) | $276.80 K(-4.7%) |
| Mar 2013 | - | $326.70 K(+2513.6%) | $290.50 K(+18.6%) |
| Dec 2012 | $245.00 K(-138.7%) | $12.50 K(-114.5%) | $245.00 K(+1.3%) |
| Sept 2012 | - | -$86.10 K(-330.2%) | $241.90 K(+78.4%) |
| June 2012 | - | $37.40 K(-86.7%) | $135.60 K(-140.5%) |
| Mar 2012 | - | $281.20 K(+2891.5%) | -$334.70 K(-47.1%) |
| Dec 2011 | -$632.70 K(-8.3%) | $9400.00(-104.9%) | -$632.80 K(-26.7%) |
| Sept 2011 | - | -$192.40 K(-55.6%) | -$862.90 K(-15.2%) |
| June 2011 | - | -$432.90 K(+2461.5%) | -$1.02 M(+60.9%) |
| Mar 2011 | - | -$16.90 K(-92.3%) | -$632.70 K(-8.3%) |
| Dec 2010 | -$690.30 K(+30.3%) | -$220.70 K(-36.5%) | -$690.20 K(+20.6%) |
| Sept 2010 | - | -$347.50 K(+630.0%) | -$572.50 K(+117.1%) |
| June 2010 | - | -$47.60 K(-36.0%) | -$263.70 K(-50.4%) |
| Mar 2010 | - | -$74.40 K(-27.8%) | -$531.90 K(+0.4%) |
| Dec 2009 | -$529.90 K(-54.6%) | -$103.00 K(+166.1%) | -$530.00 K(-26.3%) |
| Sept 2009 | - | -$38.70 K(-87.7%) | -$719.00 K(-41.5%) |
| June 2009 | - | -$315.80 K(+335.6%) | -$1.23 M(-6.0%) |
| Mar 2009 | - | -$72.50 K(-75.2%) | -$1.31 M(+12.1%) |
| Dec 2008 | -$1.17 M(-233.9%) | -$292.00 K(-46.9%) | -$1.17 M(+42.7%) |
| Sept 2008 | - | -$549.70 K(+39.2%) | -$818.30 K(-404.5%) |
| June 2008 | - | -$394.80 K(-672.2%) | $268.70 K(-47.4%) |
| Mar 2008 | - | $69.00 K(+20.6%) | $510.80 K(-41.4%) |
| Dec 2007 | $872.10 K(+13.2%) | $57.20 K(-89.4%) | $872.10 K(-7.5%) |
| Sept 2007 | - | $537.30 K(-451.9%) | $943.00 K(+51.3%) |
| June 2007 | - | -$152.70 K(-135.5%) | $623.30 K(-16.3%) |
| Mar 2007 | - | $430.30 K(+235.9%) | $744.30 K(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | $770.70 K(-17.8%) | $128.10 K(-41.1%) | $770.60 K(-16.3%) |
| Sept 2006 | - | $217.60 K(-786.4%) | $920.30 K(+8.7%) |
| June 2006 | - | -$31.70 K(-106.9%) | $846.30 K(-13.8%) |
| Mar 2006 | - | $456.60 K(+64.4%) | $981.50 K(+4.6%) |
| Dec 2005 | $938.00 K(+676.5%) | $277.80 K(+93.5%) | $938.00 K(+48.5%) |
| Sept 2005 | - | $143.60 K(+38.7%) | $631.70 K(+35.0%) |
| June 2005 | - | $103.50 K(-74.9%) | $467.90 K(+83.9%) |
| Mar 2005 | - | $413.10 K(-1549.5%) | $254.50 K(+110.7%) |
| Dec 2004 | $120.80 K(-128.2%) | -$28.50 K(+41.1%) | $120.80 K(-283.9%) |
| Sept 2004 | - | -$20.20 K(-81.6%) | -$65.70 K(-43.1%) |
| June 2004 | - | -$109.90 K(-139.3%) | -$115.40 K(-47.4%) |
| Mar 2004 | - | $279.40 K(-230.0%) | -$219.50 K(-48.8%) |
| Dec 2003 | -$429.00 K(-180.5%) | -$215.00 K(+207.6%) | -$429.00 K(-1621.3%) |
| Sept 2003 | - | -$69.90 K(-67.3%) | $28.20 K(-78.5%) |
| June 2003 | - | -$214.00 K(-406.2%) | $131.40 K(-58.3%) |
| Mar 2003 | - | $69.90 K(-71.1%) | $314.90 K(-40.9%) |
| Dec 2002 | $533.10 K(-20.5%) | $242.20 K(+627.3%) | $533.20 K(-23.9%) |
| Sept 2002 | - | $33.30 K(-209.2%) | $700.70 K(+20.4%) |
| June 2002 | - | -$30.50 K(-110.6%) | $581.80 K(-25.5%) |
| Mar 2002 | - | $288.20 K(-29.7%) | $780.60 K(+16.4%) |
| Dec 2001 | $670.90 K(+62.3%) | $409.70 K(-578.6%) | $670.80 K(+21.5%) |
| Sept 2001 | - | -$85.60 K(-150.9%) | $551.90 K(+1.9%) |
| June 2001 | - | $168.30 K(-5.7%) | $541.80 K(+38.1%) |
| Mar 2001 | - | $178.40 K(-38.7%) | $392.30 K(-5.1%) |
| Dec 2000 | $413.40 K(-32.8%) | $290.80 K(-403.9%) | $413.30 K(+78.5%) |
| Sept 2000 | - | -$95.70 K(-609.0%) | $231.60 K(-52.4%) |
| June 2000 | - | $18.80 K(-90.6%) | $486.50 K(+4.0%) |
| Mar 2000 | - | $199.40 K(+82.8%) | $467.70 K(-17.7%) |
| Dec 1999 | $615.00 K(>+9900.0%) | $109.10 K(-31.5%) | $568.30 K(+23.8%) |
| Sept 1999 | - | $159.20 K(>+9900.0%) | $459.20 K(+53.1%) |
| June 1999 | - | $0.00(-100.0%) | $300.00 K(0.0%) |
| Mar 1999 | - | $300.00 K(>+9900.0%) | $300.00 K(+200.0%) |
| Dec 1998 | $0.00(-100.0%) | $0.00(0.0%) | $100.00 K(-78.1%) |
| Sept 1998 | - | $0.00(0.0%) | $456.70 K(+28.0%) |
| June 1998 | - | $0.00(-100.0%) | $356.70 K(+127.6%) |
| Mar 1998 | - | $100.00 K(-72.0%) | $156.70 K(-39.0%) |
| Dec 1997 | $256.70 K(-356.7%) | $356.70 K(-456.7%) | $256.70 K(-14.4%) |
| Sept 1997 | - | -$100.00 K(-50.0%) | $300.00 K(+50.0%) |
| June 1997 | - | -$200.00 K(-200.0%) | $200.00 K(0.0%) |
| Mar 1997 | - | $200.00 K(-50.0%) | $200.00 K(>+9900.0%) |
| Dec 1996 | -$100.00 K(<-9900.0%) | $400.00 K(-300.0%) | $0.00(-100.0%) |
| Sept 1996 | - | -$200.00 K(0.0%) | -$400.00 K(+33.3%) |
| June 1996 | - | -$200.00 K(<-9900.0%) | -$300.00 K(+50.0%) |
| Mar 1996 | - | $0.00(0.0%) | -$200.00 K(+100.0%) |
| Dec 1995 | $0.00(-100.0%) | $0.00(-100.0%) | -$100.00 K(-66.7%) |
| Sept 1995 | - | -$100.00 K(0.0%) | -$300.00 K(+50.0%) |
| June 1995 | - | -$100.00 K(-200.0%) | -$200.00 K(<-9900.0%) |
| Mar 1995 | - | $100.00 K(-150.0%) | $0.00(0.0%) |
| Dec 1994 | -$300.00 K(+200.0%) | -$200.00 K(<-9900.0%) | $0.00(-100.0%) |
| Sept 1994 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| June 1994 | - | $100.00 K(0.0%) | $100.00 K(>+9900.0%) |
| Mar 1994 | - | $100.00 K(-200.0%) | $0.00(-100.0%) |
| Dec 1993 | -$100.00 K(-66.7%) | -$100.00 K(<-9900.0%) | -$100.00 K(0.0%) |
| Sept 1993 | - | $0.00(0.0%) | -$100.00 K(-50.0%) |
| June 1993 | - | $0.00(0.0%) | -$200.00 K(+100.0%) |
| Mar 1993 | - | $0.00(-100.0%) | -$100.00 K(-50.0%) |
| Dec 1992 | -$300.00 K(-78.6%) | -$100.00 K(0.0%) | -$200.00 K(-33.3%) |
| Sept 1992 | - | -$100.00 K(-200.0%) | -$300.00 K(-57.1%) |
| June 1992 | - | $100.00 K(-200.0%) | -$700.00 K(-36.4%) |
| Mar 1992 | - | -$100.00 K(-50.0%) | -$1.10 M(-26.7%) |
| Dec 1991 | -$1.40 M(+180.0%) | -$200.00 K(-60.0%) | -$1.50 M(+36.4%) |
| Sept 1991 | - | -$500.00 K(+66.7%) | -$1.10 M(+22.2%) |
| June 1991 | - | -$300.00 K(-40.0%) | -$900.00 K(+28.6%) |
| Mar 1991 | - | -$500.00 K(-350.0%) | -$700.00 K(+40.0%) |
| Dec 1990 | -$500.00 K(-44.4%) | $200.00 K(-166.7%) | -$500.00 K(-44.4%) |
| Sept 1990 | - | -$300.00 K(+200.0%) | -$900.00 K(+50.0%) |
| June 1990 | - | -$100.00 K(-66.7%) | -$600.00 K(-45.5%) |
| Mar 1990 | - | -$300.00 K(+50.0%) | -$1.10 M(+1000.0%) |
| Dec 1989 | -$900.00 K | -$200.00 K(<-9900.0%) | -$100.00 K(-200.0%) |
| Sept 1989 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| June 1989 | - | -$600.00 K(-185.7%) | $100.00 K(-85.7%) |
| Mar 1989 | - | $700.00 K | $700.00 K |
FAQ
- What is ImmuCell annual operaing income?
- What is the all time high annual operating profit for ImmuCell?
- What is ImmuCell annual operating profit year-on-year change?
- What is ImmuCell quarterly operating income?
- What is the all time high quarterly operating profit for ImmuCell?
- What is ImmuCell quarterly operating profit year-on-year change?
- What is ImmuCell TTM operating income?
- What is the all time high TTM operating profit for ImmuCell?
- What is ImmuCell TTM operating profit year-on-year change?
What is ImmuCell annual operaing income?
The current annual operating profit of ICCC is -$5.75 M
What is the all time high annual operating profit for ImmuCell?
ImmuCell all-time high annual operaing income is $2.12 M
What is ImmuCell annual operating profit year-on-year change?
Over the past year, ICCC annual operaing income has changed by -$3.45 M (-150.03%)
What is ImmuCell quarterly operating income?
The current quarterly operating profit of ICCC is -$574.90 K
What is the all time high quarterly operating profit for ImmuCell?
ImmuCell all-time high quarterly operating income is $918.20 K
What is ImmuCell quarterly operating profit year-on-year change?
Over the past year, ICCC quarterly operating income has changed by +$609.10 K (+51.44%)
What is ImmuCell TTM operating income?
The current TTM operating profit of ICCC is -$3.27 M
What is the all time high TTM operating profit for ImmuCell?
ImmuCell all-time high TTM operating income is $2.12 M
What is ImmuCell TTM operating profit year-on-year change?
Over the past year, ICCC TTM operating income has changed by +$3.11 M (+48.81%)